Angiotech Pharmaceuticals, Inc.
1618 Station Street
Vancouver
British Columbia
V6A 1B6
Canada
Tel: 604-221-7676
Fax: 604-221-2330
Website: http://www.angiotech.com/
Email: info@angio.com
232 articles about Angiotech Pharmaceuticals, Inc.
-
Stimwave Names Industry Veterans Paul LaViolette and Jeffrey Goldberg to Board of Directors
8/23/2018
Stimwave LLC announced today that Paul LaViolette and Jeff Goldberg joined Stimwave’s Board of Directors.
-
Angiotech Pharmaceuticals, Inc. Completes Sale To Investor Syndicate Led By Vivo Capital And ZQ Capital
3/21/2017
-
Vivo Capital And ZQ Capital Limited Enter Into An Agreement To Acquire Angiotech Pharmaceuticals, Inc.
12/19/2016
-
Angiotech Pharmaceuticals, Inc. Announces K. Thomas Bailey Departure From Board Of Directors
2/24/2015
-
Angiotech Pharmaceuticals, Inc. Appoints John Barr As CEO
10/9/2014
-
Angiotech Pharmaceuticals, Inc. Announces Changes to Management and Board of Directors
10/11/2013
-
Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast of Second Quarter 2013 Results
7/25/2013
-
Angiotech Pharmaceuticals, Inc. Announces Return of Capital to Common Shareholders
6/3/2013
-
Angiotech Pharmaceuticals, Inc. Announces Redemption of Its Senior Floating Rate Notes Due 2013 and of Angiotech Pharmaceuticals (US), Inc.'s Senior 9% Notes Due 2016
4/16/2013
-
Angiotech Pharmaceuticals, Inc. Announces Close of Sale of Interventional Products Business to Argon Medical Devices, Inc.
4/15/2013
-
Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2012
3/29/2013
-
Angiotech Pharmaceuticals, Inc. Sells Some Assets to Argon Medical Devices, Inc. for $326.5 Million
3/25/2013
-
Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast - Fourth Quarter and Year End 2012 Financial Results
3/19/2013
-
Angiotech Pharmaceuticals, Inc. Receives FDA Approval for its Proprietary Bio-Seal Lung Biopsy Device
12/26/2012
-
Angiotech Pharmaceuticals, Inc. Partner Cook Medical Receives FDA Approval for Its Zilver Stent
11/19/2012
-
Angiotech Pharmaceuticals, Inc. Narrows Losses Following Bankruptcy, Restructuring
11/19/2012
-
Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2012
11/15/2012
-
Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
11/2/2012
-
Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2012
8/15/2012
-
Angiotech Pharmaceuticals, Inc. Announces Expiration of Exchange Offer for up to $225,000,000 of Its Senior Floating Rate Notes Due 2013
8/13/2012